Kerri Ailene McGreal MD

Physician

3901 Rainbow BlvdStop 3002Kansas City, KS 66160
Phone+1 913-588-6074
Fax+1 913-588-3867

Dr. McGreal is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. McGreal's full profile Already have an account?

Summary

Kerri McGreal, MD, is a Nephrology specialist based in Kansas City, KS. She completed her medical education and subsequent training in Internal Medicine and Nephrology at the University of Kansas School of Medicine. Since 2016, she has been an Assistant Professor at The University of Kansas Hospital. Dr. McGreal has contributed to several publications, including articles in the American Journal of Kidney Diseases and Kidney360, which have been cited multiple times. Additionally, she is involved in clinical trials, specifically exploring the effects of hydralazine in polycystic kidney disease patients.

Education & Training

University of Kansas School of MedicineFellowship, Nephrology, 2013 - 2016
University of Kansas School of MedicineResidency, Internal Medicine, 2010 - 2013
University of Kansas School of MedicineClass of 2010

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

KS State Medical License 2013 - 2027
MO State Medical License 2021 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Clinical Trials

Assessing a Dose-Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients Start of enrollment: 2018 Apr 23
COMPLETED
EARLY_PHASE1

Publications & Presentations

PubMed

3 citations
Real-World Tolvaptan Use in Autosomal Dominant Polycystic Kidney Disease: Insights from Two US Medical Centers.
Vinamratha Rao, Shahed Ammar, Abrar Alshorman, Michelle Fravel, Kerri A McGreal
Kidney360. 2025-09-01
Progressive Kidney Dysfunction With Weight Loss: A Quiz.
Niveditha Girimaji, Emmanuel A Adomako, Kerri McGreal, Duncan B Johnstone
American Journal of Kidney Diseases. 2025-05-01
7 citations
A Systematic Review of Reported Outcomes in ADPKD Studies.
Sara S Jdiaa, Nedaa M Husainat, Razan Mansour, Mohamad A Kalot, Kerri McGreal
Kidney International Reports. 2022-09-01